Publications, Resources & Guidelines

Maximizing the quality of care for patients with lung cancer through vital educational resources, and informational tools for care providers.
Resources tools stock

Explore IASLC's catalog of Atlases, staging resources, new and archived guidelines, tobacco cessation materials for providers and patients, and other vital multidisciplinary tools available to IASLC members and other interested users. Search below by keyword, resource type, or timeliness.

Featured

Search For
Meeting Materials

Thank You NACLC Sponsors

Thank you to all of our industry sponsors for NACLC 2023.
Download (1022.73 KB)
IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer in Spanish
Molecular Atlas Resource

IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer in Spanish

The IASLC’s latest Atlas provides a comprehensive overview of all current and emerging molecular...
Download (21.92 MB)
IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer in Japanese
Molecular Atlas Resource

IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer in Japanese

The IASLC’s latest Atlas provides a comprehensive overview of all current and emerging molecular...
Download (24 MB)
The IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer in Chinese
Molecular Atlas Resource

IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer in Chinese

The IASLC’s latest Atlas provides a comprehensive overview of all current and emerging molecular...
Download (23.16 MB)
Tobacco Statement Graphic
Tobacco Declarations

IASLC Position Statement on Tobacco Cessation After a Cancer Diagnosis

Download (139.03 KB)
IASLC Position Statement on the Documentation of Tobacco Use in Cancer Clinical Trials
Tobacco Declarations

IASLC Position Statement on the Documentation of Tobacco Use in Cancer Clinical Trials

Download (157.42 KB)
shaverdashvili full page
General

Metastatic NSCLC with ROS1 Rearrangement and Multiple Acquired Resistance Mechanisms to Tyrosine Kinase Inhibitor Therapy: Chasing the Target

Khvaramze Shaverdashvili, MD Timothy F. Burns, MD, PhD United States
Download (1.32 MB)
Nathany Full page
General

Turning EGFR-Mutant NSCLC into a Chronic Disease: A Perfect Union between Medical Oncology & Molecular Pathology

Shrinidhi Nathany, MBBS, MD, DipRCPath India
Download (1.12 MB)